Bridgeway Capital Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Buy |
142,295
+61,500
| +76% | +$67.7K | ﹤0.01% | 1010 |
|
|
2025
Q1 | $79.2K | Sell |
80,795
-189,200
| -70% | -$185K | ﹤0.01% | 1079 |
|
|
2024
Q4 | $421K | Buy |
269,995
+4,700
| +2% | +$7.33K | 0.01% | 851 |
|
|
2024
Q3 | $974K | Buy |
265,295
+18,800
| +8% | +$69K | 0.02% | 696 |
|
|
2024
Q2 | $816K | Buy |
246,495
+15,000
| +6% | +$49.7K | 0.02% | 744 |
|
|
2024
Q1 | $986K | Sell |
231,495
-4,700
| -2% | -$20K | 0.02% | 748 |
|
|
2023
Q4 | $425K | Hold |
236,195
| – | – | 0.01% | 978 |
|
|
2023
Q3 | $470K | Sell |
236,195
-50,000
| -17% | -$99.5K | 0.01% | 895 |
|
|
2023
Q2 | $733K | Buy |
286,195
+115,900
| +68% | +$297K | 0.02% | 806 |
|
|
2023
Q1 | $683K | Hold |
170,295
| – | – | 0.02% | 810 |
|
|
2022
Q4 | $228K | Buy |
170,295
+50,000
| +42% | +$67K | 0.01% | 1059 |
|
|
2022
Q3 | $237K | Buy |
120,295
+50,000
| +71% | +$98.5K | 0.01% | 1102 |
|
|
2022
Q2 | $167K | Buy |
+70,295
| New | +$167K | ﹤0.01% | 1128 |
|